Fusion Antibodies (LON:FAB) Shares Up 9.4% – Still a Buy?

Fusion Antibodies plc (LON:FAB)’s share price rose 9.4% during trading on Monday . The stock traded as high as GBX 9.50 ($0.12) and last traded at GBX 9.30 ($0.11). Approximately 643,059 shares were traded during trading, a decline of 73% from the average daily volume of 2,371,604 shares. The stock had previously closed at GBX 8.50 ($0.10).

Fusion Antibodies Trading Up 9.4 %

The company has a quick ratio of 2.36, a current ratio of 3.87 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of £8.87 million, a price-to-earnings ratio of -232.50 and a beta of 0.49. The company has a fifty day moving average of GBX 6.43 and a two-hundred day moving average of GBX 4.60.

About Fusion Antibodies

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.